Rates and Risk Factors for Future Stress Urinary Incontinence Surgery after Pelvic Organ Prolapse Repair in a Large Population-based Cohort in California.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2019
Historique:
received: 01 08 2018
revised: 22 08 2018
accepted: 05 09 2018
pubmed: 18 9 2018
medline: 16 5 2019
entrez: 18 9 2018
Statut: ppublish

Résumé

To determine the rate and risk factors for future stress urinary incontinence (SUI) surgery in a large population-based cohort of previously continent women following pelvic organ prolapse (POP) repair without concomitant SUI treatment. Data from the Office of Statewide Health Planning and Development were used to identify all women who underwent anterior, apical, or combined anteroapical POP repair without concomitant SUI procedures in the state of California between 2005 and 2011 with at least 1-year follow-up. Patient and surgical characteristics were explored for associations with subsequent SUI procedures. Of 41,689 women undergoing anterior or apical POP surgery, 1,504 (3.6%) underwent subsequent SUI surgery with a mean follow-up time of 4.1 years. Age (odds ratio [OR] 1.01), obesity (OR 1.98), use of mesh at the time of POP repair (OR 2.04), diabetes mellitus (OR 1.19), white race, and combined anteroapical repair (OR 1.30) were associated with increased odds of future SUI surgery. The rate of subsequent surgery for de novo SUI following POP repair on a population level is low. Patient and surgical characteristics may alter a woman's individual risk and should be considered in surgical planning.

Identifiants

pubmed: 30222995
pii: S0090-4295(18)30957-9
doi: 10.1016/j.urology.2018.09.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-86

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Raveen Syan (R)

Department of Urology, Stanford University, Stanford, CA. Electronic address: rsyan@stanford.edu.

Kai B Dallas (KB)

Department of Urology, Stanford University, Stanford, CA.

Ericka Sohlberg (E)

Department of Urology, Stanford University, Stanford, CA.

Lisa Rogo-Gupta (L)

Department of Obstetrics & Gynecology, Stanford University, Stanford, CA.

Christopher S Elliott (CS)

Department of Urology, Stanford University, Stanford, CA.

Ekene A Enemchukwu (EA)

Department of Urology, Stanford University, Stanford, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH